Literature DB >> 11872739

Interdomain interaction of Stat3 regulates its Src homology 2 domain-mediated receptor binding activity.

Tong Zhang1, Kah Tong Seow, Chin Thing Ong, Xinmin Cao.   

Abstract

Activation of Stat proteins by cytokines is initiated by their Src homology 2 (SH2) domain-mediated association with the cytokine receptors. Previously, we identified an essential role of the coiled-coil domain of Stat3 in binding of the receptor peptides derived from the interleukin-6 receptor subunit, gp130. In this study, we further investigated the molecular basis of this regulation. We found that the C-terminal domain of Stat3 negatively regulates its receptor binding activity only in the absence of the first alpha-helix of the coiled-coil domain, which leads to a hypothesis of intramolecular interaction. Physical interactions between the coiled-coil domain and the C-terminal domain, as well as the SH2 domain, were indeed detected. Furthermore, a sub-region of the C-terminal domain (amino acids 720-740), which is also involved in the interaction with the coiled-coil domain, was demonstrated to be critical for the regulation of the receptor binding. Correspondingly, phosphorylation on Ser-727 within this region inhibits this interaction. In agreement with the peptide binding results, both the coiled-coil domain and the C-terminal sub-region are necessary for the functional recruitment of Stat3 to the cellular gp130 in response to interleukin-6, suggesting that the interdomain interaction is a prerequisite for the SH2-mediated receptor binding in interleukin-6 signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872739     DOI: 10.1074/jbc.M105525200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Calyculin A reveals serine/threonine phosphatase protein phosphatase 1 as a regulatory nodal point in canonical signal transducer and activator of transcription 3 signaling of human microvascular endothelial cells.

Authors:  Carlos Zgheib; Fouad A Zouein; Rony Chidiac; Mazen Kurdi; George W Booz
Journal:  J Interferon Cytokine Res       Date:  2011-12-05       Impact factor: 2.607

2.  GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction.

Authors:  Chengchen Lufei; Jing Ma; Guochang Huang; Tong Zhang; Veronica Novotny-Diermayr; Chin Thing Ong; Xinmin Cao
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

3.  Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway.

Authors:  Feng Li; Peramaiyan Rajendran; Gautam Sethi
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

4.  STAT3 regulation by S-nitrosylation: implication for inflammatory disease.

Authors:  Jinsu Kim; Je-Seong Won; Avtar K Singh; Anand K Sharma; Inderjit Singh
Journal:  Antioxid Redox Signal       Date:  2014-02-14       Impact factor: 8.401

5.  Protein tyrosine phosphatase Meg2 dephosphorylates signal transducer and activator of transcription 3 and suppresses tumor growth in breast cancer.

Authors:  Fuqin Su; Fangli Ren; Yu Rong; Yangmeng Wang; Yongtao Geng; Yinyin Wang; Mengyao Feng; Yanfang Ju; Yi Li; Zhizhuang J Zhao; Kun Meng; Zhijie Chang
Journal:  Breast Cancer Res       Date:  2012-03-06       Impact factor: 6.466

6.  Sensitivity analysis of intracellular signaling pathway kinetics predicts targets for stem cell fate control.

Authors:  Alborz Mahdavi; Ryan E Davey; Patrick Bhola; Ting Yin; Peter W Zandstra
Journal:  PLoS Comput Biol       Date:  2007-07       Impact factor: 4.475

Review 7.  Dancing rhinos in stilettos: The amazing saga of the genomic and nongenomic actions of STAT3 in the heart.

Authors:  Fouad A Zouein; Mazen Kurdi; George W Booz
Journal:  JAKSTAT       Date:  2013-05-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.